A Mathematical Model of Risk Factors in HIV/AIDS Transmission Dynamics: Observational Study of Female Sexual Network in India

2020 ◽  
Vol 14 (6) ◽  
pp. 967-976
2015 ◽  
Vol 08 (04) ◽  
pp. 1550047 ◽  
Author(s):  
Antonio Mastroberardino ◽  
Yuanji Cheng ◽  
Ahmed Abdelrazec ◽  
Hao Liu

In this paper, a nonlinear mathematical model is presented for the transmission dynamics of HIV/AIDS in Cuba. Due to Cuba's highly successful national prevention program, we assume that the only mode of transmission is through contact with those yet to be diagnosed with HIV. We find the equilibria of the governing nonlinear system, perform a linear stability analysis, and then provide results on global stability.


Author(s):  
Kehinde Adekunle Bashiru

A Mathematical Model of HIV/AIDS with Heterosexual transmission in the presence of treatment was examine in this paper, it ascertained the impact of treated individuals on the transmission dynamics of HIV/AIDS. Equilibrium points of the model system were found, stability analysis and numerical simulation were carried out, it was discovered that HIV/AIDS can die out with test of time as Ro < 1 . It was observed that the model had a disease free equilibrium which was asymptotically stable for Ro < 1 and unstable for Ro > 1. Graphical representations of the numerical analysis showing the effect of treatment on the model were also presented.


2012 ◽  
Vol 32 (S 01) ◽  
pp. S39-S42 ◽  
Author(s):  
S. Kocher ◽  
G. Asmelash ◽  
V. Makki ◽  
S. Müller ◽  
S. Krekeler ◽  
...  

SummaryThe retrospective observational study surveys the relationship between development of inhibitors in the treatment of haemophilia patients and risk factors such as changing FVIII products. A total of 119 patients were included in this study, 198 changes of FVIII products were evaluated. Results: During the observation period of 12 months none of the patients developed an inhibitor, which was temporally associated with a change of FVIII products. A frequent change of FVIII products didn’t lead to an increase in inhibitor risk. The change between plasmatic and recombinant preparations could not be confirmed as a risk factor. Furthermore, no correlation between treatment regimens, severity, patient age and comorbidities of the patients could be found.


AIDS Care ◽  
2015 ◽  
Vol 27 (7) ◽  
pp. 844-848 ◽  
Author(s):  
Jeremy Y. Chow ◽  
Marcella Alsan ◽  
Wendy Armstrong ◽  
Carlos del Rio ◽  
Vincent C. Marconi

2020 ◽  
Vol 26 (5) ◽  
pp. 1067-1068
Author(s):  
Marion Brooks ◽  
Jean‐Marc Classe ◽  
Romuald Wernert ◽  
Pedro Raro ◽  
Nicolas Paillocher ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document